scholarly journals Spiritual well-being and its association with health-related quality of life in primary brain tumor patients

2021 ◽  
Author(s):  
Dina M Randazzo ◽  
Frances McSherry ◽  
James E Herndon ◽  
Mary L Affronti ◽  
Eric S Lipp ◽  
...  

Abstract Background Spirituality can impact patients’ attitudes and decisions about treatment and end-of-life care when coping with cancer. Previous studies documented health-related quality of life (HRQoL) and spiritual well-being (SWB) as positively correlated within a general cancer patient population, but little is known about their association in the primary brain tumor population. We sought to measure SWB in primary brain tumor patients and evaluate whether it was associated with HRQoL. Methods Six-hundred and six patients treated at The Preston Robert Tisch Brain Tumor Center at Duke between December 16, 2013 and February 28, 2014 with data in the PRoGREss registry are included in this retrospective analysis. Each patient completed the Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being 12 (FACIT-Sp-12) and -Fatigue (FACIT-F), and the Functional Assessment of Cancer Therapy-General and -Brain (FACT-G and FACT-Br). Results Mean age was 49.1 years (SD = 13.5 years), male (N = 328, 54.1%), married (N = 404, 66.7%), at least college-educated (N = 381, 62.9%), and diagnosed with a high-grade glioma (N = 412, 68.0%). Multiple regression analyses were performed on both the FACT-G and the FACT-Br using the FACIT-Sp-12 sub-scales of Meaning/Peace and Faith, FACIT-F, belief in God or a higher power, prayer, gender, tumor grade, and Karnofsky Performance Status (KPS) as predictors. We found that greater SWB (measured by FACIT-Sp-12) was associated with better HRQoL (measured by FACT-G and FACT-Br; p < .0001). Conclusion The association between reported SWB and reported improved HRQoL emphasizes the importance of spirituality in primary brain tumor patients, suggesting SWB must be considered in strategies to improve HRQoL.

2014 ◽  
Vol 16 (suppl 5) ◽  
pp. v182-v183
Author(s):  
D. Randazzo ◽  
M. Affronti ◽  
E. Lipp ◽  
F. McSherry ◽  
J. Herndon ◽  
...  

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 9553-9553
Author(s):  
Dina M Randazzo ◽  
Frances McSherry ◽  
James E. Herndon ◽  
Mary Lou Affronti ◽  
Eric S. Lipp ◽  
...  

2014 ◽  
Vol 16 (suppl 5) ◽  
pp. v179-v179
Author(s):  
A. Bunevicius ◽  
S. Tamasauskas ◽  
V. P. Deltuva ◽  
A. Tamasauskas ◽  
R. Bunevicius

2013 ◽  
Vol 156 (2) ◽  
pp. 367-374 ◽  
Author(s):  
Adomas Bunevicius ◽  
Sarunas Tamasauskas ◽  
Vytenis Deltuva ◽  
Arimantas Tamasauskas ◽  
Andrius Radziunas ◽  
...  

2007 ◽  
Vol 25 (18_suppl) ◽  
pp. 4558-4558 ◽  
Author(s):  
L. Kvols ◽  
J. E. Glusman ◽  
E. A. Hahn ◽  
E. Wang ◽  
K. Öberg ◽  
...  

4558 Background: Pasireotide is a novel multi-ligand somatostatin analogue with high affinity binding for four of the five somatostatin receptor subtypes (sst1,2,3 and sst5). This Phase II clinical trial showed that pasireotide is effective in controlling the symptoms of diarrhea and flushing in 27% of patients with metastatic carcinoid tumors refractory or resistant to octreotide LAR. The impact of pasireotide therapy on health-related quality of life (HRQL) was also evaluated. Methods: Patients in this open-label, multicenter study initially received pasireotide 300 μg sc bid which was escalated to a maximum dose of 1,200 μg sc bid until clinical response was achieved. Data are reported for the Functional Assessment of Chronic Illness Therapy-Diarrhea (FACIT-D) instrument. FACIT-D comprises the Functional Assessment of Cancer Therapy-General (FACT-G) score, which measures physical, social, emotional and functional well-being, plus a symptom-specific sub-scale which measures HRQL specific to diarrhea. FACIT-D baseline assessment was obtained on day 1 immediately before dosing, and then monthly thereafter. FACIT-D sub-scale and total scores at baseline and after 1, 2, and 3 months of pasireotide treatment are described by categories of clinical response. Results: 45 patients (mean age 61 years; range 40–83) received treatment, and 44 were eligible for the efficacy and HRQL analyses. Functional well-being scores, symptom-specific scores and total FACIT-D scores of non-responders tended to be lower at baseline and during treatment than those of responders. The three sub-scale and summary FACIT-D scores exhibited relatively stable mean HRQL scores and similar patterns of variability in clinical responders and non- responders through the third month of pasireotide treatment. Conclusions: HRQL was stable during treatment with pasireotide in patients with advanced metastatic disease refractory or resistant to octreotide LAR. Additional work in HRQL study design and evaluation of HRQL endpoints in patients with carcinoid disease is indicated, and will further improve our understanding of quality of life in patients with this disease. [Table: see text]


2018 ◽  
Vol 4 (3) ◽  
Author(s):  
Nasira Hayat ◽  
Suhaib Bin Bilal Hafi ◽  
Farhana Badar ◽  
Irfan Ahmed

Purpose: Radical cystectomy is carried out for muscle invasive bladder (BL) cancer, which greatly affects the quality of life. The objective of our study was to assess the health-related quality of life (HRQoL) in patients following radicalcystectomy.Methods: A retrospective review was done in patients that underwent radical cystectomy between July 2009 and November 2014 at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan. HRQoLassessments of 34 patients done during clinical psychology review were included in this study. HRQoL was assessed using functional assessment of cancer therapy-BL questionnaire.Results: Low scores were observed in physical well-being and emotional well-being domains with mean scores of 7.32 and 7.97, respectively. Patients scored high on social and family well-being, functional well-being and additionalconcerns, with mean scores of 24.9, 17.24 and 21.73, respectively.Conclusions: Psychological evaluation and rehabilitation should be an integral part of surveillance after radical cystectomy.Key words: Bladder cancer, functional assessment of cancer therapy-bladder, health-related quality of life, radicalcystectomy, South Asian


2020 ◽  
Vol 29 (4) ◽  
Author(s):  
Tara Gallien ◽  
Hui Bian ◽  
Juhee Kim ◽  
Ernest Tamanji Anye

The aim of this study was to determine the independent effect of existential well-being (EWB) and religious well-being (RWB), two dimensions of spiritual well-being, on various measures of health related quality of life (HQROL) in a sample of 804 young adults. Independent variables were measured using the EWB and RWB subscales of the Spiritual Well-Being Scale; dependent variables were measured using questions from the Centers for Disease Control and Prevention's HRQOL – 14 Measure. Linear and ordinal regression results found stronger associations of EWB, compared to RWB, with increased overall HQROL, more healthy days and fewer unhealthy days, and better general health status, respectively.


Sign in / Sign up

Export Citation Format

Share Document